Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    NIAID | Open Studies | diabetes
Show Display Options
RSS Create an RSS feed from your search for:
NIAID | Open Studies | diabetes
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Type 1 Diabetes Extension Study
Conditions: Type 1 Diabetes;   Diabetes Mellitus
Intervention:
2 Recruiting Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Conditions: Type 1 Diabetes Mellitus;   New-onset Type 1 Diabetes Mellitus;   T1DM;   T1D
Interventions: Drug: Tocilizumab (TCZ);   Drug: Placebo
3 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
4 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
Intervention:
5 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
6 Recruiting Sustainable East Africa Research in Community Health
Conditions: HIV;   Tuberculosis;   Hypertension;   Diabetes;   Maternal Child Health;   Cost Effectiveness
Interventions: Other: Universal ART in a streamlined care model;   Other: Annual Community Health Campaigns;   Other: Targeted PrEP, Targeted testing, and Targeted care interventions;   Other: Baseline community-based HIV and multi-disease testing

Study has passed its completion date and status has not been verified in more than two years.